Bactobio Spotlight: Funding round
announcement and upcoming change of name

Celebrating Our Recent Funding Round and Rebranding

We are thrilled to announce the successful closure of our latest funding round, which raised an impressive £2.8 million.

This oversubscribed round marks a significant milestone in our journey, bolstering our network of esteemed angel investors and advisors who are instrumental in shaping our path forward. Among our distinguished advisors are industry titans such as Peder Holk Nielsen (former CEO & President of Novozymes), Leopoldo Zambeletti (former Head of Healthcare at JP Morgan), Jonathan Milner (Founder of Abcam), and Claudio Costamagna (former Chairman of Goldman Sachs (EMEA)). We are also delighted to welcome Hugh Grant(former Chairman & CEO of Monsanto), a renowned expert within the agritech sector.

In conjunction with this exciting development, we are proud to announce our rebranding as Bactobio, a name that embodies our company’s continuous growth trajectory.

For more details, please refer to the full report of our funding round.